This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Oncogenomics: Wilbert Zwart

Research interest: Hormone-Associated Cancers

As a lab, we position ourselves as a multidisciplinary translational endocrinology group. As such, we operate at the intersection of genomics, pathology, cell biology and molecular pathology. I strongly believe that combining specialities from different research fields is key for innovative translational science in cancer research. The hormone-related mechanisms in transcriptional regulation of breast cancer, endometrial cancer and prostate cancer are tightly linked, creating many opportunities for synergy between the research lines in the lab. The central theme of our research projects revolves around personalized cancer treatment, where we aim to identify novel biomarkers and to unravel the underlying biological mechanisms. 

 

Co-workers

Experience

Close this window
Flach, Koen.jpg

Koen D Flach, MSc

Ph.D. Student

Experience

I performed my Master Oncology training at the VU University Medical Center, Amsterdam during 2010-2012. My first internship was at the Cancer Center Amsterdam in 2011 in the group of Prof. dr. G.J. Peters. My second internship was at the Netherlands Cancer Institute, Amsterdam in the group of Wilbert Zwart, where I, after finishing my Master's, started as a PhD-student. At the moment I'm working on a genomics-based tool to predict the tamoxifen response in ER-positive breast cancer tumors. Additionally I'm studying the spatial and temporal regulation of the ERα-transcription complex.

 

Close this window
Joosten, Stacey

Stacey Joosten, MSc

Ph.D. Student

Experience

In 2012, I obtained a bachelor degree in biomedical sciences at the VU University of Amsterdam. My bachelor internship at the Hubrecht Institute inspired me to specialize in oncology. I enrolled in the master Oncology at the VU University Medical Centre, for which I performed two additional internships at the Cancer Centre Amsterdam and the NKI-AVL. I also pursued a degree in healthcare policy.

Recently, I joined the lab of Wilbert Zwart as a PhD student. In collaboration with the group of Sabine Linn, we aim to develop a predictive profile for endocrine treatment in breast cancer.  

 

Close this window
Kim, Yongsoo.jpg

Yongsoo Kim

Postdoctoral fellow

Experience

I studied computer science during my undergraduate study at Pohang University of Science and Technology (POSTECH), South Korea. During my Ph.D training, I participated in systems biology lab (Prof. Daehee Hwang) and machine learning lab (Prof. Seungjin Choi), and my research is dedicated to computational systems biology.

I joined labs of Wilbert Zwart and Lodewyk Wessels to contribute to cancer research computationally. My project is funded through a Alpe d'HuZes/ KWF Bas Mulder project awarded to Wilbert, aimed to identify novel applications of existing hormonal drugs.

 

Close this window
Mayayo Peralta, Isabel

Isabel Mayayo Peralta

Ph.D. Student

Experience

I graduated in Medical Biochemistry from the University of Navarra (Spain). Next, I obtained my Master's degree in Medical Biology from the University of Amsterdam. Being interested in oncological research, I joined the lab of Dr Wilbert Zwart as a PhD student in December 2016.

In my project, I will focus on progressive metastatic breast cancer. With this project we aim to gain new insights into the proteomic, genomic and epigenetic landscape of the metastatic disease in relation to personalised therapeutic approaches.

Close this window
Schunselaar, Laurel.jpg

Laurel Schunselaar

Ph.D. Student

Experience

In October 2012, I obtained my master degree in Technical medicine.
I performed my master internship, about primary tumor cultures of malignant pleural mesothelioma (MPM), in the lab of Sjaak Neefjes. After my master internship, I continued working at the project as a phd-student. Since the move of Sjaak Neefjes to the LUMC,  I'm working in the lab of Wilbert Zwart.
My main project is about personalized medicine for patients with mesothelioma. With chemosensitivity screens on primary tumor cultures we determine second line treatment for patients. 
This project is in collaboration with the thoracic oncology department, under supervision of Paul Baas and Sjaak Neefjes.

Close this window
Stelloo, Suzan.jpg

Suzan Stelloo, MSc

Ph.D. Student

Experience

I received my Bachelor degree in molecular biology from the hogeschool Utrecht, and then I graduated from the Utrecht University. During the master program Cancer Genomics & Developmental biology I performed an internship at the UMC Utrecht in the group of dr. Derksen and a second in the lab of Prof. Melino at the University Tor Vergata, Rome. In February 2013, I started as a PhD student in the lab of Wilbert Zwart & André Bergman. My work focuses on integrative androgen receptor genomics as a readout for recurrence risk and treatment resistance of prostate cancer.

 

 

Close this window
Zhu, Yanyun

Yanyun Zhu

Ph.D. Student

Experience

I did my master in Wageningen University in food safety from 2013 to 2015. During my study, I followed my interest in oncology and did both of my master thesis and internship in this field, which studied the mutation of TP53 gene and the ERα positive breast cancer, in the toxicology department (the group of professor Ivonne Rietjens) of Wageningen University. 
Motivated by my strong interest in oncology, I decided to do a Ph.D. after I finished my master. In July 2016, I joined the groups of Wilbert Zwart and Andre Bergman as a Ph.D. student. My project focusses on biomarker discovery for response to Enzalutamide treatment in prostate cancer.

Close this window
silhouette_geen_foto_thumb_man.jpg

Jeroen Kneppers

PhD student

Experience

As a 2016 MSc Molecular Life Sciences graduate from Wageningen University (WUR), I have investigated gene editing tools such as CRISPR-Cas12a in the Zhang lab at the Broad Institute, Cambridge, USA. My current technical expertise are in Molecular Biology, Next Generation Sequencing (NGS) and CRISPR. My research project at the NKI focuses on interactions of nuclear receptors in the prostate cancer microenvironment. Eventually, it is my hope that our findings results in the discovery of better prognostic biomarkers, which will enable improved personalized treatment of patients.

Close this window
silhouette_geen_foto_thumb_man.jpg

Simon Linder

PhD student

Experience

I obtained my Bachelor's as well as my Master's degree in Biomolecular Engineering from the Technical University of Darmstadt, Germany. Within my Master's studies I have performed an internship at the Netherlands Cancer Institute in the lab of René Medema. In June 2017, I joined the groups of Wilbert Zwart and André Bergman as a Ph.D. student. Here, my project focuses on genome-wide profiling of Androgen Receptor action in clinical specimens, in search of biomarkers for prognostication and treatment selection in prostate cancer.

Close this window

Key publications View All Publications

  • Androgen receptor profiling predicts prostate cancer outcome

    (2015) EMBO Mol Med. Sep 27. pii: e201505424. doi: 10.15252/emmm.201505424. [Epub ahead of print]

    Stelloo S, Nevedomskaya E, van der Poel HG, de Jong J, van Leenders GJ, Jenster G, Wessels LF, Bergman AM, Zwart W.

    Link to PubMed
  • Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancer

    (2013) Cancer Res. Nov 15;73(22):6632-41. doi: 10.1158/0008-5472.CAN-13-0704

    Jansen MP, Knijnenburg T, Reijm EA, Simon I, Kerkhoven R, Droog M, Velds A, van Laere S, Dirix L, Alexi X, Foekens JA, Wessels L, Linn et al.

    Link to PubMed
 
 

Recent publications View All Publications

  • The Estrogen Receptor α-Cistrome Beyond Breast Cancer

    (2016) Mol Endocrinol. Oct;30(10):1046-1058.

    Droog M, Mensink M, Zwart W.

    Link to PubMed
  • The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer

    (2016) Urol Case Rep. May 26;7:67-9. doi: 10.1016/j.eucr.2016.04.010. eCollection 2016 Jul.

    Van der Roest RC, van Houdt PJ, Heijmink SW, de Jong J, Bergman AM, Zwart W, van der Heide UA, van der Poel HG.

    Link to PubMed
 

Contact

  • E-mail

    a.laan@nki.nl

  • Telephone Number

    +31 20 512 2015

silhouette_geen_foto_thumb_vrouw.jpg

Donate

'Our goal is to fully personalize hormonal cancer treatment. To know which drug to give and to understand why it works. Support our research to help us achieve this goal.'

Support us
Share this page